T1	Pregnancy_considerations 0 354	Subject is pregnant, or lactating, or of childbearing potential (to be considered of non-childbearing potential, a female must be post-menopausal for at least 1 year, surgically sterile, or using an effective method of contraception or abstinence from at least 4 weeks prior to the first vaccination and until at least 4 weeks after the last vaccination.
T2	Non-query-able 356 576	Participation in the 4 weeks preceding the first trial vaccination, or planned participation during the present trial period, in another clinical trial investigating a vaccine, drug, medical device, or medical procedure.
T3	Drug 612 626	rabies vaccine
T4	Drug 659 681	rabies immune globulin
T5	Observation 578 594	Previous history
T6	Observation 629 645	Previous history
R1	Has_temporal Arg1:T3 Arg2:T5	
R2	Has_temporal Arg1:T4 Arg2:T6	
T7	Condition 688 714	major psychiatric disorder
T8	Qualifier 724 730	severe
T9	Condition 731 741	depression
R3	Has_qualifier Arg1:T9 Arg2:T8	
T10	Qualifier 743 749	severe
T11	Condition 750 766	anxiety disorder
R4	Has_qualifier Arg1:T11 Arg2:T10	
T12	Condition 768 777	psychosis
T13	Condition 779 792	schizophrenia
T14	Condition 800 827	major psychiatric disorders
T15	Qualifier 794 799	other
R5	Has_qualifier Arg1:T14 Arg2:T15	
T16	Condition 832 840	seizures
T17	Qualifier 853 857	mild
T18	Condition 858 868	depression
T19	Condition 872 888	anxiety disorder
T20	Negation 918 921	not
T21	Qualifier 898 913	well controlled
*	OR T18 T19
T22	Scope 858 888	depression or anxiety disorder
R6	Has_qualifier Arg1:T22 Arg2:T17	
R7	Has_qualifier Arg1:T22 Arg2:T21	
R8	Has_negation Arg1:T22 Arg2:T20	
*	OR T16 T14 T13 T12 T11 T9
T23	Scope 724 840	severe depression, severe anxiety disorder, psychosis, schizophrenia, other major psychiatric disorders, or seizures
R9	Subsumes Arg1:T7 Arg2:T23	
T24	Drug 954 976	immunosuppressive drug
T25	Temporal 977 1001	at the time of the study
T26	Temporal 1005 1023	30 days previously
*	OR T25 T26
T27	Scope 977 1023	at the time of the study or 30 days previously
R10	Has_scope Arg1:T24 Arg2:T27	
T28	Drug 1025 1041	Topical steroids
T29	Negation 1047 1050	not
R11	Has_negation Arg1:T28 Arg2:T29	
R12	AND Arg1:T24 Arg2:T28	
T30	Condition 1156 1182	immunosuppressive disorder
T31	Condition 1192 1205	HIV infection
T32	Condition 1207 1239	common variable immunodeficiency
T33	Temporal 1241 1247	active
T34	Condition 1248 1255	cancers
T35	Procedure 1259 1271	chemotherapy
*	OR T35 T34
T36	Scope 1248 1271	cancers or chemotherapy
R13	Has_temporal Arg1:T36 Arg2:T33	
*	OR T32 T36 T31
T37	Scope 1192 1271	HIV infection, common variable immunodeficiency, active cancers or chemotherapy
R14	Subsumes Arg1:T30 Arg2:T37	
T38	Condition 1285 1304	renal insufficiency
T39	Observation 1274 1281	History
T40	Procedure 1318 1326	dialysis
T41	Mood 1308 1317	requiring
R15	Has_mood Arg1:T40 Arg2:T41	
*	OR T38 T40
T42	Scope 1285 1326	renal insufficiency or requiring dialysis
R16	Has_temporal Arg1:T42 Arg2:T39	
T43	Post-eligibility 1329 1523	Have any condition that would, in the opinion of the site investigator, place the subject at an unacceptable risk of injury or render the subject unable to meet the requirements of the protocol.
T44	Post-eligibility 1525 1843	Identified as an employee of the Investigator or study center, with direct involvement in the proposed study or other studies under the direction of that Investigator or study center, as well as family members (i.e., immediate, husband, wife and their children, adopted or natural) of the employee or the Investigator.
T45	Condition 1854 1870	adverse reaction
T46	Temporal 1845 1853	Previous
T47	Drug 1885 1903	antimalarial drugs
T48	Qualifier 1904 1922	used in this study
R17	Has_qualifier Arg1:T47 Arg2:T48	
R18	Has_temporal Arg1:T45 Arg2:T46	
R19	AND Arg1:T45 Arg2:T47	
